SCLX - Scilex Holding Co

8.48
0.060   0.708%

Share volume: 22,584
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$8.42
0.06
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 43%
Dept financing 43%
Liquidity 4%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.46%
1 Month
-1.51%
3 Months
-52.70%
6 Months
-61.75%
1 Year
2,322.86%
2 Year
497.18%
Key data
Stock price
$8.48
P/E Ratio 
0.00
DAY RANGE
$7.98 - $8.48
EPS 
-$24.77
52 WEEK RANGE
$0.18 - $34.27
52 WEEK CHANGE
$2,322.86
MARKET CAP 
136.888 M
YIELD 
N/A
SHARES OUTSTANDING 
7.585 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
2.85
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$38,326
AVERAGE 30 VOLUME 
$39,359
Company detail
CEO: Jaisim Shah
Region: US
Website: scilexholding.com
Employees: 80
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Vickers Vantage Corp. I does not have significant operations. The company was incorporated in 2020 and is based in Singapore. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or reorganization.

Recent news